Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Wolozin

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Archives of Neurology|January 21, 2003
Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer diseaseBenjamin Wolozin
Current Opinion in Lipidology|November 6, 2004
Cholesterol, statins and dementiaBenjamin Wolozin
Neuron|April 19, 2019
The Evolution of Phase-Separated TDP-43 in StressBenjamin Wolozin
Neuron|January 13, 2004
Cholesterol and the biology of Alzheimer's diseaseBenjamin Wolozin
Discovery Medicine|January 14, 2014
Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative diseaseBenjamin Wolozin
Alzheimer'S Research & Therapy|January 24, 2012
Statins and therapy of Alzheimer's disease: questions of efficacy versus trial designBenjamin Wolozin
Molecular Neurodegeneration|November 21, 2012
Regulated protein aggregation: stress granules and neurodegenerationBenjamin Wolozin
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Peering into proteolysis with presenilinsBenjamin Wolozin
Archives of Neurology|August 18, 2004
Apolipoprotein E receptor LR11: intersections between neurodegeneration and cholesterol metabolismBenjamin Wolozin
Biological Psychiatry|September 5, 2018
Disrupted in DementiaBenjamin Wolozin
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Archives of Neurology|January 21, 2003
Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer diseaseBenjamin Wolozin
Current Opinion in Lipidology|November 6, 2004
Cholesterol, statins and dementiaBenjamin Wolozin
Neuron|April 19, 2019
The Evolution of Phase-Separated TDP-43 in StressBenjamin Wolozin
Neuron|January 13, 2004
Cholesterol and the biology of Alzheimer's diseaseBenjamin Wolozin
Discovery Medicine|January 14, 2014
Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative diseaseBenjamin Wolozin
Alzheimer'S Research & Therapy|January 24, 2012
Statins and therapy of Alzheimer's disease: questions of efficacy versus trial designBenjamin Wolozin
Molecular Neurodegeneration|November 21, 2012
Regulated protein aggregation: stress granules and neurodegenerationBenjamin Wolozin
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Peering into proteolysis with presenilinsBenjamin Wolozin
Archives of Neurology|August 18, 2004
Apolipoprotein E receptor LR11: intersections between neurodegeneration and cholesterol metabolismBenjamin Wolozin
Biological Psychiatry|September 5, 2018
Disrupted in DementiaBenjamin Wolozin
Pageof 13